J&J | JNJ - Ativo Circulante

Preço das Ações
227.50
Mudança Diária
-3.15 -1.37%
Mensal
-5.18%
Anual
47.17%
Q2 Previsão
222.63




Ativo Circulante Alterar Data
AbbVie USD 29.06B 523M 2025-12
Abbott USD 26B 1.16B 2025-12
Amgen USD 29.06B 1.17B 2025-12
AstraZeneca USD 28.72B 1.22B 2025-12
Baxter International USD 6.87B 61M 2025-12
Bayer EUR 32.91B 30M 2025-12
Becton, Dickinson and Co. USD 9.19B 66M 2025-12
Biogen USD 8.97B 37.5M 2025-12
Boston Scientific USD 8.79B 759M 2025-12
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
CONMED USD 672.86M 10.7M 2025-12
Cooper Companies USD 2.13B 27.4M 2025-12
Dexcom USD 4.03B 1.19B 2025-12
Edwards Lifesciences USD 6.74B 380M 2025-12
Eli Lilly USD 55.63B 6.44B 2025-12
Gilead Sciences USD 19.89B 1.05B 2025-12
GlaxoSmithKline GBP 17.51B 332M 2025-12
Globus Medical USD 2.13B 201.25M 2025-12
Insulet USD 1.91B 54.6M 2025-12
Integra LifeSciences USD 1.16B 15.96M 2025-12
Intuitive Surgical USD 11.52B 881.5M 2026-03
J&J USD 59.17B 3.55B 2026-03
Medtronic USD 24.07B 75M 2025-12
Merck USD 47.56B 10.49B 2025-09
Merit Medical Systems USD 1.04B 54.62M 2025-12
Novartis USD 30.46B 2.26B 2025-12
Pfizer USD 46.92B 3.22B 2025-09
Regeneron Pharmaceuticals USD 18.02B 41.2M 2025-12
Roche Holding CHF 38.73B 3.03B 2025-12
Sanofi EUR 30.16B 789M 2026-03
Stryker USD 14.76B 1.04B 2025-12
Tandem Diabetes Care USD 618.14M 1.2M 2025-12
Teva Pharmaceutical Industries USD 13.95B 1.21B 2025-12
Vertex Pharmaceuticals USD 11.2B 631.4M 2025-12
Zimmer Biomet Holdings USD 5.12B 715M 2025-12
Zoetis USD 6.77B 185M 2025-12